Inhibition of phospholipase A2 increases Tau phosphorylation at Ser214 in embryonic rat hippocampal neurons

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 1, 2010, Pages 57-60

  De Paula, Vanessa J ^a   Schaeffer, Evelin L ^a   Talib, Leda L ^a   Gattaz, Wagner F ^a   Forlenza, Orestes V ^a  

^a Laboratory of Neuroscience LIM 27   (Brazil)

Author keywords

Alzheimer's disease; Hippocampus; Neurons; Phospholipase A2; Tau protein

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; METHYLARACHIDONYLFLUOROPHOSPHONATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN ANTIBODY; SERINE; TAU PROTEIN; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; ENZYME INHIBITOR; METHYL ARACHIDONYLFLUOROPHOSPHONATE; PHOSPHONIC ACID DERIVATIVE; PHOSPHOSPECIFIC ANTIBODY;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE CELL; PHOSPHORYLATION; PRENATAL DEVELOPMENT; PROTEIN PROCESSING; WISTAR RAT;

RATTUS;

ANIMALS; ANTIBODIES, PHOSPHO-SPECIFIC; ARACHIDONIC ACIDS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HIPPOCAMPUS; NEURONS; PHOSPHOLIPASES A2; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; PHOSPHONIC ACIDS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; SERINE; TAU PROTEINS;

EID: 73949119890     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.07.006     Document Type: Article

References (24)

1. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of Tau protein mRNAs in human brain. EMBO J. 8 (1989) 393-399
2. Drechsel D.N., Hyman A.A., Cobb M.H., et al. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein Tau. Mol. Biol. Cell 3 (1992) 1141-1154
3. Buée L., Bussière T., Buée-Scherrer V., et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33 (2000) 95-130
4. Hernández F., and Avila J. Tauopathies. Cell. Mol. Life Sci. 64 (2007) 2219-2233 (7)
5. Vuillet J., Dimova R., Nieoullon A., et al. Ultrastructural relationships between choline acetyltransferase- and neuropeptide y-containing neurons in the rat striatum. Neuroscience 46 (1992) 351-360
6. Kobayashi S., Ishiguro K., Omori A., et al. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett. 335 (1993) 171-175
7. Hanger D.P., Hughes K., Woodgett J.R., et al. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147 (1992) 58-62
8. Mazanetz M.P., and Fischer P.M. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat. Rev. Drug Discovery 6 (2007) 464-479
9. Iqbal K., and Grundke-Iqbal I. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies. Curr. Drug Targets 5 (2004) 495-502
10. Gattaz W.F., Maras A., Cairns N.J., et al. Decreased phospholipase A2 activity in Alzheimer brains. Biol. Psychiatry 37 (1995) 13-17
11. Gattaz W.F., Cairns N.J., Levy R., et al. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 246 (1996) 129-131
12. Lukiw W.J., and Bazan N.G. Neuroinflammatory signaling upregulation in Alzheimer's disease. Neurochem. Res. 25 (2000) 1173-1184
13. Sierra F.G., Rodríguez S.M., and Islas G.B. Truncation of tau protein and its pathological significance in Alzheimer's disease. J. Alzheimers Dis. 14 (2008) 401-409
14. Balsinde J., Winstead M.V., and Dennis E.A. Phospholipase A (2) regulation of arachidonic acid mobilization. FEBS Lett. 531 (2002) 2-6
15. Mendes C.T., Gattaz W.F., Schaeffer E.L., et al. Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons. J. Neural Transm. 112 (2005) 1297-1308
16. Lowry O.H., Rowebrough N.J., Farr L.A., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Fuentes L., Pérez R., Nieto M.L., et al. Bromoenol lactone promotes cell death by a mechanism involving phosphatidate phosphohydrolase-1 rather than calciumindependent phospholipase A2. J. Biol. Chem. 278 (2003) 44683-44690
18. Forlenza O.V., Mendes C.T., Marie S.K., et al. Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. Prostaglandins Leukot Essent. Fatty Acids 76 (2007) 47-55
19. Farooqui A.A., Litsky M.L., Farooqui T., et al. Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49 (1999) 139-153
20. Vijayan S., El-Akkad E., Grundke-Iqbal I., et al. A pool of beta-tubulin is hyperphosphorylated at serine residues in Alzheimer disease brain. FEBS Lett. 1509 (2001) 375-381
21. Ksiezak-Reding H., Pyo H.K., Feinstein B., et al. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of Tau protein in vitro. Biochim. Biophys. Acta 1639 (2003) 159-168
22. Bennecib M., Gong C.X., Grundke-Iqbal I., et al. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of Tau in rat forebrain. FEBS Lett. 485 (2000) 87-93
23. Murray A.J. Pharmacological PKA inhibition: all may not be what it seems. Sci. Signal (2008) 3-4
24. Kyoung P.H., Lovati E., Pasinetti G.M., and Ksiezak-Redingm H. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT. Neuroscience 27 3 (2004) 649-658